Results 301 to 310 of about 311,527 (352)
Some of the next articles are maybe not open access.

Unlabeled uses of botulinum toxins: a review, part 2.

American Journal of Health-System Pharmacy, 2006
PURPOSE Efficacy and safety data regarding the unlabeled uses of botulinum toxins are reviewed, and the pharmacology, adverse effects, and characteristics of commercially available botulinum toxins are discussed.
Christine M. Cheng   +2 more
semanticscholar   +1 more source

Botulinum Toxin A

2001
Bereits der Name Botulinum Toxin A verrat viel uber die Historie einer Substanz, die in den letzten Jahren eine sprunghafte Karriere vom Gift zum Arzneimittel erfahren hat. Bekannt geworden ist das Toxin als Verursacher des Botulismus, einer Lebensmittelvergiftung, die durch verdorbene Wurst- und Konservenwaren (Botulus lat.
Mall, Volker   +4 more
openaire   +3 more sources

Botulinum Toxin for Rhinitis

Current Allergy and Asthma Reports, 2016
Rhinitis is a common clinical entity. Besides nasal obstruction, itching, and sneezing, one of the most important symptoms of rhinitis is nasal hypersecretion produced by nasal glands and exudate from the nasal vascular bed. Allergic rhinitis is an IgE-mediated inflammatory reaction of nasal mucosa after exposure to environmental allergens.
Cengiz Özcan, Onur Ismi
openaire   +3 more sources

Topical botulinum toxin

2016
Nanotechnology is a rapidly growing discipline that capitalizes on the unique properties of matter engineered on the nanoscale. Vehicles incorporating nanotechnology have led to great strides in drug delivery, allowing for increased active ingredient stability, bioavailability, and site-specific targeting. Botulinum toxin has historically been used for
Ashley Collins, Adnan Nasir
openaire   +3 more sources

Pharmacology of botulinum toxin

Journal of the American Academy of Dermatology, 2000
Botulinum toxin has a well-defined role among dermatologists for the treatment of facial wrinkling, brow position, and palmar and axillary hyperhidrosis.The purpose of this study is to educate dermatologists on the pharmacology of botulinum toxin.A retrospective review of the literature on botulinum toxin from 1962 to the present was conducted.
Wilber Huang   +2 more
openaire   +2 more sources

Use of enzyme-linked immunoassays for antibody to types C and D botulinum toxins for investigations of botulism in cattle.

Australian Veterinary Journal, 1996
The development of specific enzyme-linked immunosorbent assays (ELISA) for antibody to types C and D Clostridium botulinum toxins for investigation of botulism in cattle is described.
Gregory Ar   +4 more
semanticscholar   +1 more source

Periocular botulinum toxin

Clinics in Dermatology, 2003
Botulinum toxin type A (BOTOX, Dysport) has revolutionized treatment of wrinkles around the eyes. Since the first publications of its cosmetic benefit by Drs. Jean and Alastair Carruthers, hundreds of articles have been published about its cosmetic use. BOTOX holds U.S.
openaire   +3 more sources

Botulinum Toxin and Pain

2020
This chapter is focused on analgesic mechanism of action of botulinum toxin type A (BoNT-A) including the action beyond peripheral nerve endings. With the exception of the meninges and possibly urinary bladder, the presence of BoNT-A activity in the periphery, cleaving SNAP25 as a target molecule, up to now was not convincingly shown.
openaire   +3 more sources

HEAT INACTIVATION RATES OF BOTULINUM TOXINS A, B, E AND F IN SOME FOODS AND BUFFERS

, 1979
Inactivation of botulinum toxins was determined in selected acid and low acid foods and buffer systems. Heating at 74°C and 79°C gave a biphasic curve when the log of the inactivation of the toxins was plotted against the time of heating.
M. Woodburn   +3 more
semanticscholar   +1 more source

Botulinum Toxin in Ophthalmology

Survey of Ophthalmology, 2007
Since its introduction into clinical medicine in 1980, botulinum toxin has become a major therapeutic drug with applications valuable to many medical sub-specialties. Its use was spearheaded in ophthalmology where its potential applications have expanded to cover a broad range of visually related disorders.
Amy M. Fowler, Jonathan J. Dutton
openaire   +3 more sources

Home - About - Disclaimer - Privacy